Physician profile
Ali Tural
NPI 1750369310
$3,100.14
in general payments reported to CMS, 2019-2025
16 companies · $587 in 2025
The $587 reported for 2025 was more than what 95% of Pediatrics providers received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $360 · 2020: $56.55 · 2021: $415 · 2022: $253 · 2023: $1,001 · 2024: $428 · 2025: $587.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,015.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,015.31 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Supernus Pharmaceuticals, INC. | $728.25 | 2021-2025 | Qelbree, Qelbree |
| Corium, LLC | $596.98 | 2022-2025 | Azstarys |
| Ironshore Pharmaceuticals INC. | $515.12 | 2019-2024 | Jornay Pm |
| Glaxosmithkline, LLC. | $276.52 | 2019-2023 | Bexsero, Rotarix |
| Pfizer INC. | $170.48 | 2019-2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $168.98 | 2019-2021 | |
| Merck Sharp & Dohme LLC | $130.90 | 2023-2025 | Vaxelis, Gardasil 9, M-M-R II |
| Collegium Pharmaceutical, INC. | $105.49 | 2025 | Jornay Pm |
| Astrazeneca Pharmaceuticals LP | $80.95 | 2021-2023 | Flumist Quadrivalent |
| Seqirus USA INC | $66.70 | 2021-2024 | Flucelvax Quadrivalent, Flucelvax |
| Sanofi Pasteur INC. | $65.61 | 2019-2023 | |
| Covis Pharma Gmbh | $60.38 | 2021 | |
| Cranial Technologies, INC | $56.68 | 2023-2025 | Doc Band |
| Alk-Abello, INC | $41.19 | 2023 | Grastek, Odactra, Ragwitek |
| Ars Pharmaceuticals Operations, INC. | $23.62 | 2025 | Neffy |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shire North American Group INC | $12.29 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ali Tural listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.